On January 22, the fifth subject was enrolled in our ongoing study of MDMA-assisted psychotherapy for PTSD taking place in Boulder, Colorado. (Note: We are now subtracting dropouts from the total number …
On January 7, 2014, MAPS Clinical Research Associate Mimi Peleg completed the regularly scheduled site monitoring visit for our ongoing Israeli study of MDMA-assisted psychotherapy for PTSD. The study …
On January 2, 2014, the third subject received their second experimental treatment in our ongoing Israeli study of MDMA-assisted psychotherapy for 10 subjects with chronic, treatment-resistant PTSD. The …
On December 20, 2013, the fifth subject received their first experimental treatment in our ongoing study of MDMA-assisted psychotherapy for PTSD in Boulder, Colorado. The same day, the U.S. Drug Enforcement …
On December 6, 2013, the fourth subject began treatment in our ongoing Boulder, Colorado, study of MDMA-assisted psychotherapy for 17 subjects with chronic, treatment-resistant PTSD. This subject was enrolled …
On November 27, 2013, the third subject began treatment in our ongoing Israeli study of MDMA-assisted psychotherapy for 10 subjects with chronic, treatment-resistant PTSD. Goals for this study include …
On November 22, 2013, the first telephone screening took place in our new Canadian study of MDMA-assisted psychotherapy for 12 subjects with chronic, treatment-resistant PTSD. This marks the official start …
Ongoing study Location: Beer Yaakov, Israel Clinical Investigator: Moshe Kotler, M.D. Estimated study budget: $463,000 Already raised: $39,000 Needed to complete this study: $423,000 …
On October 4 and 9, 2013, the second and third subjects were treated in our ongoing Boulder, Colorado, study of MDMA-assisted psychotherapy for 17 subjects with PTSD. The second and third subjects are …
On September 6, 2013, Health Canada approved the amended protocol for our new Canadian study of MDMA-assisted psychotherapy in 12 subjects with chronic, treatment-resistant PTSD! After working for over …
On August 27, 2013, the Journal of Psychopharmocology published a Letter to the Editor arguing that our completed Swiss study of MDMA-assisted psychotherapy for PTSD had a large effect size not previously …
